Work

Glucagon-like Peptide-1 Receptor Agonists in Treating Diabetes Mellitus and Weight Loss with Potential Application to Rare Obesity-related Genetic Disorders: A Commentary

Year: 2026

Type: article

Abstract: Glucagon-like peptide-1 (GLP1) and receptor (GLP1R) agonists are now in common use for treating type 2 diabetes mellitus and weight loss as major global health burdens affecting millions worldwide with prevalence of both diagnosed and undiagnosed diabetes approaching 15% for all U.S.

Source: Journal of Cellular Signaling

DOI: 10.33696/signaling.7.153

Authors: Lucas Francis, Merlin G. Butler

Institutions: Kansas City University, University of Kansas Medical Center

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Institute of Child Health and Human Development